Case File
efta-efta00981761DOJ Data Set 9OtherFrom: Laurie Cameron alMille
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00981761
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Laurie Cameron alMille
To: Jeffrey Epstein <[email protected]>
Subject: then and now
Date: Wed, 22 Jan 2014 05:16:28 +0000
Good morning,
I hope your birthday was fun, peaceful, happy.
Last year spot and forward trading beat option trading thanks to the losses incurred in
October. I learned that the greatest short of the year is companies that sell OTC pricing
models (FENICS, Superderivatives) as these pricers no longer predict bank prices. I spent
an enormous amount of time trying to replicate/predict the prices that JPM used in its
models. I never managed to do it (I always could in the past).
I respect what you said about young and hungry traders having sharper and more
aggressive strategies than I do (I should never have made the stupid comment about
French multinational's USD revenue to support my EUR view). You deserve more
aggressive coverage.
I read Bloomberg all day, scour for tenacious opinions that are too slow to change and
volatility above historic levels. It is harder and harder to find high FX vol in investment
grade economies. It is impossible to trade instruments whose price you can't predict. I
think there will surely be good FX ideas this year (short BRL) a young trader on a trading
desk will be able to give you tradable ideas quicker than I will.
Although I cut my teeth on FX and FX option trading, I have been also trading Pro Shares
"ultra" (double) short ETF options. They are very profitable in strong directional markets
and markets that rise and stall. My recommendation is to sell BZQ Puts below 8o any
time the spot rate moves to 83-85. On a strong directional move above 98, I would look to
also sell calls above 1OO. Short calls work well with double short ETFs as any market
except a strongly directional move higher will erode the value of the underlying due to the
compounding. And vol is 47%.
SCO (double short crude) is also interesting below 3o and puts are worth selling below 33
(33.77 close today so we re close). Vol is approx 39%. I also like trading GLL (sell puts
below 88 and calls above 1O5). Vol has fallen to 35%.
Listed option prices are completely transparent but liquidity is limited. These trades may
be too small to keep you interested.
Please let me know your thoughts. I respect and understand that there are younger kids
who sit on trading desks who can get you quicker prices and ideas which are much closer to
the action. I am grateful that I had the chance to be one of those people once upon a time.
EFTA00981761
I appreciate your giving me a second chance very much. I'm sorry it was such a difficult
time.
Please let me know what time I should call you to speak live. One of my children is getting
her tonsils out tomorrow am do I will be home after 1 pm and can call any time.
Laurie
EFTA00981762
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.